NCT04107051View on ClinicalTrials.gov

Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients with Alcohol Dependence

CompletedOBSERVATIONAL
Enrollment

533

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

February 7, 2023

Study Completion Date

February 6, 2024

Conditions
Alcohol Dependence
Interventions
DRUG

Nalmefene Hydrochloride Hydrate

Oral administration of nalmefene hydrochloride hydrate

Trial Locations (1)

Unknown

Otsuka Pharmaceutical Co., Ltd., Osaka

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

NCT04107051 - Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients with Alcohol Dependence | Biotech Hunter | Biotech Hunter